How to Talk to Your Doctor About TRT

Why the Conversation Matters

Testosterone replacement therapy (TRT) is a medical treatment for clinically diagnosed hypogonadism — not a lifestyle upgrade you order online. Getting it right starts with a productive conversation between you and a qualified provider. That conversation determines whether you receive a thorough evaluation or a hasty prescription, whether your underlying causes get investigated or overlooked, and whether your long-term monitoring plan is comprehensive or nonexistent.

Many men walk into their doctor's office saying "I think I need testosterone" and walk out with either a dismissal or a prescription — neither of which serves them well without proper context. The goal is not to convince your doctor to prescribe TRT. The goal is to communicate your symptoms clearly, ensure the right diagnostic work gets done, and collaborate on a treatment plan that addresses root causes rather than masking them.

Before the Appointment

The single most valuable thing you can do before talking to your doctor about TRT is arrive with lab work already in hand. Many primary care physicians will order a basic testosterone test if you ask, but "basic" often means total testosterone alone — which does not tell the full story. Request a comprehensive hormone panel that includes the following markers:

• Total testosterone — The combined amount of bound and free testosterone in your blood. Reference ranges vary by lab but typically fall between 264-916 ng/dL.
• Free testosterone — The biologically active fraction, usually 2-3% of total. This is what your body can actually use. Request calculated free testosterone if available, as direct assays tend to be less accurate.
• SHBG (sex hormone-binding globulin) — The protein that binds testosterone and makes it unavailable. High SHBG can mask adequate total levels by leaving very little free testosterone.
• LH (luteinizing hormone) and FSH (follicle-stimulating hormone) — These pituitary hormones signal your testes to produce testosterone. They help distinguish between primary hypogonadism (testes not responding) and secondary hypogonadism (pituitary not signaling).
• CBC (complete blood count) — Establishes your baseline hematocrit and hemoglobin before any treatment, since TRT can increase red blood cell production.
• Comprehensive metabolic panel — Evaluates liver and kidney function, blood glucose, and electrolytes. This rules out other conditions that can mimic low testosterone symptoms.

If your doctor is reluctant to order a full panel, direct-to-consumer lab services like Marek Health, Quest Diagnostics, or Labcorp allow you to order these tests independently. The cost for a comprehensive male hormone panel typically runs $150-300 out of pocket. Having numbers in hand shifts the conversation from "I feel bad" to "here is what my labs show."

How to Frame Your Symptoms

Doctors respond to specificity. "I am tired all the time" is vague and could indicate dozens of conditions. "Over the past six months, my energy has dropped significantly — I used to train four days a week and now I struggle to get through two sessions, and I am falling asleep by 8 PM despite sleeping 7-8 hours" tells a different story entirely.

Before your appointment, write down your symptoms with as much measurable detail as possible. Focus on changes you can quantify or time-stamp:

• Energy and fatigue — When did the decline start? How does it compare to 6-12 months ago? Does it improve or worsen at specific times of day?
• Libido and sexual function — Has your interest in sex decreased noticeably? Any changes in morning erections or erectile quality?
• Body composition — Have you gained fat despite no change in diet or exercise? Have you lost muscle despite maintaining your training program?
• Recovery — Are you more sore than usual after workouts? Do you need more rest days than before?
• Mood and cognition — Are you experiencing brain fog, irritability, or low motivation that is out of character for you?
• Sleep — Has your sleep quality changed? Are you waking up feeling unrested even after adequate hours?

Bring this written list to your appointment. Do not walk in and say "I think I need TRT" or "I read online that my testosterone might be low." Instead, describe your symptoms and let the clinical picture guide the conversation. A good provider will connect the dots. If you lead with a self-diagnosis, some physicians will become defensive or dismissive — and that works against you.

What to Expect from a Good Provider

Not every doctor is equally equipped to manage hormonal health. Primary care physicians may have limited training in endocrinology, and some hold outdated views about testosterone therapy. Knowing what a competent evaluation looks like helps you assess whether your current provider is the right fit.

A thorough provider will typically do the following:

1. Order comprehensive labs — Not just total testosterone. They should request free testosterone, SHBG, LH, FSH, estradiol, CBC, metabolic panel, thyroid panel, and possibly prolactin and cortisol if symptoms warrant it.
2. Investigate root causes — Before jumping to TRT, they should rule out conditions that lower testosterone: sleep apnea, thyroid dysfunction, obesity, chronic stress, medication side effects (opioids, certain antidepressants), and pituitary disorders.
3. Discuss all treatment options — TRT is not the only intervention. Depending on your situation, a good provider may suggest lifestyle optimization first, clomiphene citrate (which stimulates your own production), or hCG — especially if fertility preservation matters to you.
4. Explain monitoring requirements — They should outline a follow-up lab schedule (typically 6-8 weeks after starting, then every 3-6 months) and specify which markers they will track: testosterone levels, hematocrit, estradiol, PSA, and lipids.
5. Take your symptoms seriously — Even if your levels fall within the reference range. A total testosterone of 280 ng/dL in a 35-year-old is technically "normal" by most lab standards but may be clinically significant given your symptoms and age.

The best providers for TRT management tend to be endocrinologists, urologists with a focus on male health, or physicians at dedicated men's health clinics who manage hormone therapy regularly. A doctor who prescribes TRT once or twice a year is less likely to stay current on dosing protocols, monitoring, and emerging research.

Red Flags in Providers

Just as there are signs of a competent provider, there are clear warning signs that a provider may not be managing TRT appropriately. Watch for the following:

• No baseline labs before prescribing — Any provider who writes a testosterone prescription without first confirming low levels through blood work is cutting corners. You need at least two separate low readings to establish a diagnosis.
• Only offering one delivery method — Gel-only or injection-only clinics limit your options. A knowledgeable provider discusses injections, gels, creams, and pellets — and explains the trade-offs of each.
• Cookie-cutter dosing — Every patient getting 200mg testosterone cypionate weekly regardless of body weight, SHBG levels, or individual response is a red flag. Dosing should be individualized and adjusted based on labs and symptoms.
• No follow-up labs scheduled — If a provider starts you on TRT and does not schedule blood work for 6-8 weeks later, they are not monitoring you properly. Hematocrit, estradiol, and testosterone levels all need to be checked after initiation.
• Dismissing symptoms because "you are in range" — Reference ranges are population averages, not personalized targets. A provider who refuses to investigate further because your total testosterone is 290 ng/dL (technically within some labs' reference range) may be prioritizing the number over your clinical presentation.
• Pushing ancillaries from the start — A provider who immediately prescribes an aromatase inhibitor, DHEA, and multiple add-ons before seeing how you respond to testosterone alone may be prioritizing revenue over evidence-based care.

Telehealth and Men's Health Clinics

The rise of telehealth TRT clinics has made hormone therapy more accessible, particularly for men in areas without local endocrinologists or men's health specialists. These clinics typically operate on a subscription model: you pay a monthly fee that covers consultations, lab orders, and sometimes the medication itself.

There are legitimate advantages to this model. Telehealth providers who specialize in hormone therapy often have more experience with TRT protocols than a general practitioner who rarely prescribes it. Appointments are convenient, lab orders are streamlined, and medication can be shipped directly to your home. For men who have been dismissed by primary care physicians, a specialist telehealth clinic can be a turning point.

That said, the telehealth TRT space varies widely in quality. When evaluating a clinic, consider the following:

• Lab requirements — Reputable clinics require comprehensive blood work before and during treatment. If a clinic prescribes based on a questionnaire alone, that is a disqualifying red flag.
• Provider credentials — Verify that you are being treated by a licensed physician, not a mid-level provider operating with minimal oversight. Ask about the prescribing clinician's background in endocrinology or urology.
• Cost transparency — Monthly fees for telehealth TRT typically range from $100-250 per month. Be wary of clinics that require expensive proprietary compound formulations when standard pharmaceutical-grade testosterone cypionate is widely available and affordable.
• Monitoring cadence — The clinic should schedule follow-up labs at 6-8 weeks, then every 3-6 months. They should review results with you and adjust your protocol accordingly — not just auto-refill your prescription.

Whether you choose an in-person provider or a telehealth clinic, the evaluation criteria remain the same: comprehensive labs, individualized dosing, regular monitoring, and a provider who weighs your symptoms alongside the numbers.

Key Takeaways

• Arrive with data — Get comprehensive labs (total T, free T, SHBG, LH, FSH, CBC, metabolic panel) before your appointment. Morning fasted draws between 7:00-9:00 AM give the most accurate readings.
• Describe symptoms, do not self-diagnose — Focus on measurable changes in energy, libido, recovery, mood, and body composition. Bring a written list with timelines.
• A good provider investigates before prescribing — They should rule out sleep apnea, thyroid issues, and other conditions that lower testosterone before starting TRT.
• Know the red flags — No baseline labs, cookie-cutter dosing, no follow-up monitoring, and dismissing symptoms based solely on reference ranges are all warning signs.
• Telehealth clinics can be excellent or terrible — Evaluate them by the same standards as in-person providers: comprehensive labs, individualized protocols, licensed physicians, and regular monitoring.
• TRT is a partnership, not a prescription — The best outcomes come from ongoing collaboration between you and a knowledgeable provider who adjusts your protocol based on both labs and symptoms.

References

1. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. Link
2. Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of Testosterone Treatment in Older Men. N Engl J Med. 2016;374(7):611-624. Link
3. Lincoff AM, Bhasin S, Flevaris P, et al. Cardiovascular Safety of Testosterone-Replacement Therapy. N Engl J Med. 2023;389(2):107-117. Link
4. Huijben M, Lunacek A, Slagter MH, et al. Clomiphene citrate: A potential alternative for testosterone therapy in hypogonadal males. Endocrinol Diabetes Metab. 2023;6(3):e416. Link
5. Grossmann M, Matsumoto AM. A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management. J Clin Endocrinol Metab. 2017;102(3):1067-1075. Link
6. Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. J Urol. 2018;200(2):423-432. Link